Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-ONC-12002609Phase 4Completed
Phase 4, open-label, single-arm trial of sertraline in major depressive disorder (MDD), sponsored by Beijing An Zhen Hospital. Primary endpoint: Hamilton Depression Scale (HAMD-17). Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-ONC-12002609.